Finding a cure: Alzheimer’s patient helps test new drug

We are the only location in NC offering this break through study:

Why is this drug being tested?

It may be acting upstream of all the defects in Alzheimer’s brains going after the possible cause rather than the effects; at the ‘Top of the Pyramid’.

What does this drug do?

It turns on and turns off genes that regulate brain functions.

What could this drug do?

Based on studies in Alzheimer’s rats T3D-959 could:

How will this study benefit me and others?

  1. Provides critical information as a first step in the development of a potential breakthrough medicine.
  2. Guides the design of future bigger and longer trials of the drug
  3. Before you start your trial medication, your doctor can establish a baseline of how your brain is currently functioning
  4. At the end of the study you will know how the drug affected your brain scans
  5. At the end of the study you will be informed of your ApoE status
  6. Your out-of-pocket expenses for your current dementia drug therapies will be paid for 7 months
  7. You and your caregiver will be compensated for travel costs

You Might Also Enjoy...

SCRS Global Summit

New Hope attended the Global Site Solutions Summit to gain knowledge and collaborate with other industry professionals and experts in the field of clinical research. Where Sites, Sponsors & CROs Partner for Success The Global Site Solutions Summit bring

Study of Twins Provides Alzheimer’s Blood Protein Clue

A protein has been discovered in the blood of people who go on to develop mild cognitive impairment several years later. Dr. Steven Kiddle of King’s College London, UK, and colleagues explain there currently are no treatments that can reliably prevent mild

The Hope for Mental Illness

It has been 10 years since Dr. Tom Insel, director of the National Institute of Mental Health (NIMH) first started attending events held by NAMI. In that time, research on mental illness has continued to grow and new and more effective treatments for menta

3 Distinct Subtypes of Alzheimer’s

A new University of California, Los Angeles study finds that Alzheimer’s disease, long thought to be a single disease, really consists of three distinct subtypes. Experts believe the finding could lead to more highly targeted research and, eventually, new